← Back to Search

Behavioural Intervention

Oculus Go VR headset for Delayed Gastric Emptying

N/A
Waitlist Available
Led By Brian Lacy, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks

Summary

This trial is testing if virtual reality therapy is safe and effective for people with gastroparesis. Patients will use VR goggles to experience a virtual world, which might help reduce their nausea by distracting them from their symptoms.

Eligible Conditions
  • Delayed Gastric Emptying
  • Gastroparesis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Patient-reported adverse events
Secondary study objectives
Change in Quality of life
Change in work productivity
Changes in abdominal pain
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Active VR GroupExperimental Treatment1 Intervention
Subjects will be provided an Oculus Go VR headset pre-loaded with a "menu" of virtual reality programs which have been designed specifically to treat both acute and chronic pain. Subjects are required to use the VR headset at home four times daily, prior to breakfast, lunch, dinner, and bedtime. Each session will last approximately 15 minutes.
Group II: Sham VR GroupPlacebo Group1 Intervention
Subjects will be provided an Oculus Go VR headset pre-loaded two-dimensional nature video. Subjects are required to use the VR headset at home four times daily, prior to breakfast, lunch, dinner, and bedtime. Each session will last approximately 15 minutes.

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,337 Previous Clinical Trials
3,061,144 Total Patients Enrolled
Brian Lacy, MDPrincipal InvestigatorMayo Clinic
1 Previous Clinical Trials
49 Total Patients Enrolled
~0 spots leftby Dec 2024